MedTrace Logo

Occupational Therapy-Based Dance Program for Children With ADHD

NCT07731893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-07-28

No results posted yet for this study

Summary

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that can affect children's attention, movement, balance, sensory processing, and self-esteem. These difficulties may interfere with participation in daily activities, school performance, and social interactions.

The purpose of this randomized controlled trial is to evaluate whether an occupational therapy-based dance program can improve cognitive-motor performance, self-esteem, functional balance, and sensory processing in children with ADHD. Participants will be randomly assigned to either an intervention group receiving a structured 5-week occupational therapy-based dance program or a control group receiving no intervention during the study period. Outcomes will be assessed before and after the intervention using standardized assessment tools.

The study hypothesizes that children who participate in the occupational therapy-based dance program will demonstrate greater improvements in cognitive-motor performance, self-esteem, functional balance, and sensory processing than children in the control group.

Conditions

  • Attention-Deficit/Hyperactivity Disorder (ADHD)

Interventions

BEHAVIORAL

Occupational Therapy-Based Dance Program

Participants received a structured occupational therapy-based dance program for 5 weeks, consisting of two 45-minute sessions per week (10 sessions in total). The intervention included rhythm- and movement-based activities designed to improve cognitive-motor performance, self-esteem, functional balance, and sensory processing. Sessions were conducted by an occupational therapist following a standardized intervention protocol.

Sponsors & Collaborators

  • IREM CEYHAN

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-06-10
Completion
2026-06-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07731893 on ClinicalTrials.gov